BackRoivant Sciences Overview

Roivant Sciences Current Cash

Track Roivant Sciences's current cash ($1.4B) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Current Cash
$1.42B
↓ 47.59% YoYΔ $-1.29B vs prior year quarter

Peer average

Loading

Roivant Sciences Current Cash History

Loading

Roivant Sciences vs. peers: Current Cash Comparison

Loading

Roivant Sciences Cash Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Roivant Sciences (ROIV) FAQ

As of the most recent data (March 2026), ROIV shows a current cash of $1.4B. That compares with $2.7B in the prior-year period — down 47.6% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, ROIV's current cash is now $1.4B (was $2.7B) — a 47.6% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Roivant Sciences is outperforming or lagging.

Tracking ROIV's current cash over time shows whether Roivant Sciences is scaling, shrinking, or reshaping that part of the business. The current reading is $1.4B That compares with $2.7B in the prior-year period — down 47.6% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this current cash page, Stockcircle has Roivant Sciences's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect current cash (currently $1.4B) with ownership activity and broader fundamentals.